Screw Conveyor Reliability for Pharmaceutical Powder Handling

Containment requirements depend on the Occupational Exposure Limit (OEL) of the material being handled. Highly potent APIs with OELs below 10 micrograms per cubic meter may require containment levels achieving exposure below 1 microgram per cubic meter. This demands sealed conveyor designs with validated containment performance, continuous liner or split butterfly valve connections, and environmental monitoring during operation. Containment validation documentation must demonstrate achieved exposure levels.

Worn screw flights and trough liners increase the mechanical stress on granulated product as it travels through the conveyor. Excessive clearance between flight tips and the trough allows product to be crushed between the moving screw and stationary trough surface. This attrition generates fines that alter the particle size distribution, affecting downstream processing characteristics including flowability, compressibility, and dissolution rate.

Pharmaceutical-spec Screw Conveyors typically carry upgrades over general-industrial: corrosion-resistant materials matched to GMP validation, cleanroom equipment, batch traceability, sealing rated for the operating media, controls and instrumentation compliant with FDA cGMP, EU Annex 15, ICH Q7. Capital cost runs 20 to 50 percent above general industrial; lifecycle cost is usually lower because of longer service life and fewer unplanned failures in this duty.

When in-house skill gaps create unacceptable risk on Screw Conveyors reliability. Common triggers: turnover of a critical specialist (vibration analyst, sealed-system technician), regulatory finding about documentation gaps, or a major failure that revealed inadequate response capability. Outsourcing scope ranges from quarterly specialty service to full maintenance program. Cost in Pharmaceutical typically runs higher than general industrial because of FDA cGMP, EU Annex 15, ICH Q7 compliance overhead.